Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stocks

Is Quanta Services (PWR) The Most Crowded Hedge Fund Stock That is Targeted by Short Sellers?

We recently published a list of 15 Most Crowded Hedge Fund Stocks That Are Targeted by Short Sellers. In this article, we are going to take a look at where Quanta Services, Inc. (NYSE:PWR) stands against other most crowded hedge fund stocks that are …

EODHD | 14 May 2025

IZEA Announces Intention to Commence a Modified Dutch Auction Tender Offer to Repurchase up to $8.7M of its Common Stock

ORLANDO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that it intends to commence a modified “Dutch auction” tender offer (the “Offer”) to repurchase up to …

EODHD | 14 May 2025

New Data Shows Improvements in Growth and Bone Morphometry in Children with Achondroplasia Treated with TransCon® CNP (Navepegritide)

Ascendis Pharma COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ApproaCH Trial of TransCon CNP (navepegritide) in children with achondroplasia. TransCon CNP …

EODHD | 14 May 2025

Biodesix Announces First Quarter 2025 Results and Highlights

Total Q1 2025 Revenue of $18.0 million, an increase of 21% over Q1 2024; Gross margins of 79.4% for Q1 2025; Q1 2025 Net loss improved by 18% compared to Q1 2024; Updated 2025 Revenue Guidance to a range of $80-85 million; Conference Call …

EODHD | 14 May 2025

Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update

Creates commercial opportunity in the estimated up to $4.5 billion compounded hormone therapy market, enabling women to access an evidence-based solutionFour on-market products will accelerate revenue generation and provide path to profitabilityDaré expects to start recording revenue in the 4th quarter of this year …

EODHD | 14 May 2025

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

Q1 2025 revenue of $17.3 million, with product sales of $14.0 million, representing 76% growth over Q1 2024 and the 17th straight quarter of sequential product sales growthQ1 2025 basic and fully diluted GAAP EPS of $(0.06), Non-GAAP fully diluted EPS of $0.07, and …

EODHD | 14 May 2025

Fate Therapeutics Reports First Quarter 2025 Financial Results and Business Updates

Fate Therapeutics, Inc. Additional Phase 1 Data for FT819 Off-the-Shelf CAR T-cell Product Candidate in Moderate-to-Severe Systemic Lupus Erythematosus to be Featured in Oral Presentation at EULAR 2025 Congress in June Regenerative Medicine Advanced Therapy Designation Granted by the FDA for FT819 in Moderate-to-Severe …

EODHD | 14 May 2025

Gevo Reports First Quarter 2025 Financial Results

Quarterly Revenue Increased $25 Million Compared to First Quarter of 2024 Due to Strategic Growth Initiatives Further Revenue and Adjusted EBITDA1 Growth is Expected in 2025 Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., May 13, 2025 (GLOBE NEWSWIRE) -- …

EODHD | 14 May 2025

iCAD Reports Financial Results for First Quarter Ended March 31, 2025

NASHUA, N.H., May 13, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating …

EODHD | 14 May 2025

IZEA Reports Q1 2025 Revenue from Core Operations of $8.0 million, up 23%

ORLANDO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading influencer marketing company that makes Creator Economy solutions for marketers, reported its financial and operational results for the first quarter ended March 31, 2025. Q1 2025 Financial Summary Compared …

EODHD | 14 May 2025
Support

Hi! How can we help you today?

Loading…